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Abstract
Background: Previous studies have shown that complaints after episiotomy repair depend on the method and
material used for repair. The objective of our study was to determine which of two frequently used suture materials,
Monocryl® (poliglecaprone 25) and Vicryl Rapide™ (polyglactin 910), is superior for intracutaneous closure of the skin
in mediolateral episiotomies.
Methods: In a randomized controlled trial performed in a teaching hospital in the Netherlands between 2010 and
2013 250 primiparous women with uncomplicated mediolateral episiotomies were randomly allocated to
intracutaneous skin closure with either Monocryl® or Vicryl Rapide™. All other layers were sutured with Vicryl 2-0
and Vicryl 0 in both groups. Pain scores and complications were documented using questionnaires during the first
three months post partum. The primary outcome was pain 10 days after delivery in sitting position established by
Visual Analogous Scale (VAS). Secondary outcomes were pain scores at different time points and reported
complications such as infections, dehiscence and dyspareunia one day, 10 days, six weeks and three months after
delivery.
Results: Of 250 allocated women 54% returned questionnaires. No statistical difference was found between
both groups for the primary outcome (VAS 2,8 (95% CI 2,18-3,44) vs. VAS 2,5 (95% CI 2,00-2,98), p = 0,43).
With regard to secondary outcomes only self-reported dehiscence was significantly different, favouring
Monocryl® (10% vs. 25%, p = 0.016).
Conclusions: Use of Monocryl® 3-0 and Vicryl Rapide™ 3-0 for intracutaneous closure of the skin after mediolateral
episiotomy leads to equal pain scores ten days after delivery and therefore both materials may be considered for this
use. Monocryl® 3-0 might be favourable over Vicryl Rapide™ 3-0 due to less self-reported dehiscence after
intracutaneous closure of the skin in mediolateral episiotomies.
Trial registration: The trial was retrospectively registered under trial nr. ISRCTN29869308 on 20-04-2016.
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Background
Sixty to 90 % of women suffer perineal trauma during
vaginal delivery with sixty to 70 % of these injuries re-
quiring immediate repair [1–3]. Episiotomies are the
most frequently performed operative procedure during
delivery. In the Netherlands in 47% of primiparous and
15% of multiparous women an episiotomy is performed
during delivery [4, 5]. Ninety-two percent of women
delivered with an episiotomy will have complaints of
perineal pain in the postpartum period and approxi-
mately 20% of women still have complaints after three
months [6] and 10% even up to 18 months [7].
After episiotomy repair, complaints like pain and dys-
pareunia may interfere with daily lives of women. The
technique and material used in the repair may influence
the intensity and duration of these complaints [8–11].
Previous trials have shown that interrupted suturing of
the skin causes more pain when compared to continuous
intracutaneous suturing [12]. Similarly, it was shown
that synthetic materials cause a reduction in complaints
when compared to catgut [13, 14]. To date, only two
trials have compared a resorbable monofilament and a
resorbable multifilament synthetic material for the repair
of episiotomies [15, 16].
To date, few RCTs comparing Monocryl® and Vicryl
Rapide™ have been performed and no trials have looked
specifically at use of both of these materials for skin
closure in mediolateral episiotomies [17]. Both materials
are frequently used for this purpose in the Netherlands,
but differ substantially in their properties [18, 19].
It has been shown that Monocryl® causes minimal tis-
sue reaction due to the fact that as a monofilament ma-
terial it has a small surface. It is completely resorbed in
approximately 120 days. After 14 days it still holds 25%
of its tensile strength [20].
Vicryl Rapide™ is a multifilament material. Due to its
braided structure, its surface is larger and it might have
niches in which bacteria cannot easily be reached by
cells of the immune system [21]. Vicryl Rapide™ is com-
pletely resorbed in 42 days and has no tensile strength
after 14 days.
The objective of our randomized controlled trial was
to investigate whether Monocryl® or Vicryl Rapide™ is
superior with regard to pain after repair, wound infec-
tion and dehiscence after the suturing of the skin after a
vaginal delivery with a mediolateral episiotomy in prim-
iparous women.
Methods
Our trial was performed between 2010 and 2013 at
the maternity ward of a single general hospital in
Rotterdam, the Netherlands. On average this centre
provides care for almost 2000 medium and high-risk
deliveries per year. The population attending this
hospital is known to have a wide socioeconomical
and ethnical range.
Only primiparous women were included in the trial to
exclude effects of previous birth trauma and minimise
variability. Nulliparous women were informed about the
study between the 34th and 36th week of pregnancy. If
during delivery a mediolateral episiotomy was performed
women were asked to participate in the study.
Women who met the inclusion criteria were randomly
allocated to suturing of the skin with Monocryl® or Vicryl
Rapide™ after informed consent was obtained. Random as-
signment took place using opaque envelopes present on
the delivery ward. The suture material was included in the
opaque envelope containing the questionnaires. The trial
was single blinded.
Inclusion criteria were defined as primiparous women
with an uncomplicated episiotomy after a vaginal delivery.
Both women with a spontaneous and an operative delivery
were included. Uncomplicated episiotomy was defined as a
mediolateral episiotomy with no additional labial, contralat-
eral vaginal wall or perineal ruptures.
Exclusion criteria were defined as women under 18 years
of age or unable to understand the written information
about the study. Women with a coagulopathy or an
impaired immune system were excluded. Postpartum
hemorrhage, prohibiting sufficient time for inclusion, was
another exclusion criterium.
Postpartum suturing was performed in the delivery
room by the attending midwife or obstetrician. In
order to standardise the method of suturing all
episiotomies were repaired using the following
standardized protocol: The vaginal wall was sutured
continuously using Vicryl® 2-0 from the apex to the
hymen. The bulbocavernosus and superficial perineal
muscles and subcutaneous tissue were sutured with
interrupted stitches using Vicryl® 0. The skin was su-
tured intracutaneously using Monocryl® 3-0 SH or
Vicryl Rapide™ 3-0 SH. The first knot was tied in the
subcutaneous tissue at the distal end of the episiot-
omy. From here a continuous intracutaneous suture
to the fourchette was made where a knot was tied.
After randomization and perineal repair, women were
handed out a questionnaire with four sets of questions
to be answered 24 h, 10 days, six weeks and three
months after delivery. Baseline characteristics were
recorded from the hospital records. Pain scores were
evaluated using a Visual Analogous Scale, (VAS), a self-
reported pain scale from 0 to 10 cm [22]. VAS scores
were evaluated in lying and sitting position, and whilst
walking. Primary outcome was pain in sitting position
after 10 days. Secondary outcomes were self-reported
dehiscence, infections, analgesia use, necessity for re-
moval of suture material, the resumption of intercourse
and dyspareunia at 10 days, six weeks and three months.
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All the secondary outcomes were self-reported through
the questionnaires. Women received text messages on
day 10, week six and after three months as a reminder
to fill out the particular part of the questionnaires. After
three months they were asked to send back the ques-
tionnaires. Stamped return-envelopes were provided
with the questionnaires. Non-responders were contacted
by telephone and asked to send in the information (Add-
itional file 1).
Statistical analysis
Power analysis was performed prior to the study with the
assumption of a difference in VAS score of 1 cm. With a α
of 0.05 and a β of 90% it was calculated that two groups of
112 women were necessary to find statistically significant
differences. Estimating 10% loss to follow up the total
amount of inclusions was set to be 250.
Statistical analysis for the primary outcome and second-
ary pain scores was made using Student’s t-tests. Chi-s-
quare and Fishers exact test were used to investigate
differences in proportions between independent categor-
ical variables. Adjusted analyses were made using linear
regression analysis and Mantel-Haenzel tests. No interim
analyses were planned or performed. IBM SPSS Statistics
for Windows version 22.0 was used for data analysis.
The trial was approved by the Ethical Committee for
Scientific Research of Rotterdam (TWOR) ref. nr
NL28922.101.10 on the 7th October 2010 and was regis-
tered retrospectively under number ISRCTN29869308.
Results
Between November 2010 and July 2013 4995 women de-
livered in our hospital, with 2735 primiparous women
who delivered vaginally. Over the research period the
percentage of primiparous women with an episiotomy
decreased from 52 to 47%.
Two-hundred-and-fifty women were randomized.
Four inclusions were withdrawn. Three were errone-
ously included, one woman was not primiparous and
two women did not meet the inclusion criterion of an
uncomplicated mediolateral episiotomy. During repair
one woman appeared to have a complicated vaginal
wall rupture, whereas the other woman had a grade
3a rupture. For one woman two envelopes were
opened accidentally, of which only one was used.
All women received the assigned treatment. Of the
246 included women 132 returned the questionnaires
and one woman was excluded for analysis because she
had not completed the VAS scores. Therefore, statis-
tical analysis was performed on 131 women (53.3%)
(Fig. 1).
Baseline characteristics of women in both groups
showed no differences in terms of ethnicity, duration of
second stage of labour and weight of the newborn be-
tween the two trial arms (Table 1). Women who were
delivered by ventouse were more often allocated to
Vicryl Rapide™. Due to the nature of the randomization
method this unequal distribution occurred by chance.
Responders were significantly older than non-
responders and were significantly more often Caucasian.
Fig. 1 Flow chart MOVE trial
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Other characteristics did not differ significantly between
responders and non-responders (Table 2).
No significant difference was found in the primary
outcome, pain (VAS score) in sitting position at 10 days
after delivery. Furthermore, VAS scores did not show
any statistically significant differences between the
groups at any moment of comparison or in any position
(Table 3).
Analysis of the secondary outcomes (Table 4) showed
that women in the Monocryl® group reported signifi-
cantly less skin dehiscence when compared with women
in the Vicryl Rapide™ group after 10 days and within the
first three months.
No differences were found in intercourse at 10 days
post partum or in analgesia use 6 weeks and 3 months
post partum between the groups.
Women who delivered by ventouse delivery did not
show more dehiscence compared to women with a
spontaneous delivery. (Ventouse 15% vs. No ventouse
18%, P = 0.74). After correction for the difference in
ventouse deliveries in the groups the difference in
self-reported dehiscence was still statistically signifi-
cant. (10 days p = 0.021, three months p = 0.017).
Table 1 Baseline characteristics of the trial population
Monocryl (n = 64) Vicryl Rapide (n = 67)
Age (years ± SD) 31.5 ± 4.5 30.8 ± 4.4
Caucasian 57 (89%) 58 (87%)
Birth weight (gram ± SD) 3470 ± 361 3489 ± 500
Duration 2nd stage
(minutes ± SD)
40 ± 29 39 ± 27
Direct Occiput Posterior
Position
4 (6%) 2 (3%)
Ventouse delivery 7 (11%) 19 (28%)
Gestational age
(weeks ± SD)
40 + 1 ± 8.9 days 40 + 1 ± 8.6 days
Apgar score 1 min
(mean± SD)
9 ± 0.79 9 ± 0.80
Apgar score 5 min
(mean± SD)
10 ± 0.83 10 ± 0.46
Continuous variables are given as means with standard deviations [SD].
Categorical variables are given as frequencies with percentages, n (%)
Table 2 Baseline characteristics responders vs. non-responders
Reponders
(n = 132)
Non-responders
(n = 114)
p-value
Age (years, ± SD) 31,1 ± 4,5 28,4 ± 5.3 0.000
Caucasian 116 (88%) 82 (72%) 0.002
Birth weight
(gram, ± SD)
3478 ± 438 3395 ± 508 0.17
Duration 2nd stage
(minutes, ± SD)
39 ± 28 37 ± 28 0.49
Direct Occiput
Posterior Position
6 (5%) 4 (4%) 0.69
Ventouse delivery 26 (20%) 23 (20%) 0.89
Gestational age
(weeks, ± SD)
40 + 1 ± 8.6 days 40 + 1 ± 8.8 days 0.94
Apgar score 1 min
(mean ± SD)
9 ± 0.79 9 ± 0.81 0.38
Apgar score 5 min
(mean ± SD)
10 ± 0.66 10 ± 0.79 0.23
Continuous variables are given as means with standard deviations [SD].
Categorical variables are given as frequencies with percentages, n (%)
and p-values
Table 3 Primary outcomes
Monocryl
(n = 64)
Vicryl rapide
(n = 67)
p-value
VAS* 24 h sitting 6.0 ± 2.4 5.9 ± 2.4 0.80
VAS 24 h walking 5.1 ± 2.5 4.9 ± 2.5 0.72
VAS 24 h lying down 3.9 ± 2.5 3.2 ± 2.3 0.09
VAS 10 days sitting 2.8 ± 2.5 2.5 ± 2.1 0.43
VAS 10 days walking 2.1 ± 2.1 2.4 ± 2.4 0.48
VAS 10 days lying 1.5 ± 1.9 1.2 ± 1.6 0.24
VAS 6 weeks sitting 0.5 ± 1.2 0.5 ± 1.3 0.73
VAS 6 weeks walking 0.5 ± 1.0 0.3 ± 1.0 0.24
VAS 6 weeks lying 0.3 ± 0.7 0.2 ± 0.8 0.74
VAS 3 months sitting 0.06 ± 0.2 0.09 ± 0.6 0.60
VAS 3 months walking 0.06 ± 0.2 0.09 ± 0.4 0.67
VAS 3 months lying 0.03 ± 0.2 0.03 ± 0.2 0.97
Variables are given as means with standard deviations (± SD) and p-values.
*Visual Analogous Scale (0-10 cm)
Table 4 Secondary outcomes
Monocryl
(n = 64)
Vicryl rapide
(n = 67)
p-value
Analgesia use 24 h 22 (34%) 29 (43%) 0.30
Dehiscence 24 h 0 (0%) 1 (1%) 0.51
Analgesia use 10 days 5 (8%) 10 (15%) 0.20
Dehiscence 10 days 5 (8%) 15 (22%) 0.02
Infection 10 days 4 (6%) 2 (3%) 0.32
Removal of stitches
10 days
3 (5%) 8 (12%) 0.14
Intercourse 6 weeks 27 (42%) 29 (43%) 0.96
Painless intercourse
6 weeks
12 (19%) 11 (16%) 0.75
Intercourse 3 months 52 (81%) 52 (78%) 0.61
Painless intercourse
3 months
32 (50%) 39 (58%) 0.50
Dehiscence within
3 months
6 (10%) 17 (25%) 0.016
Stitches removal within
3 months
9 (11%) 8 (12%) 0.72
Infection within 3 months 4 (7%) 2 (3%) 0.37
Variables are given as frequencies with percentages, n (%) and p-values
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After correction for the difference in ventouse deliver-
ies between the Monocryl® and Vicryl Rapide™ group
there was no difference in pain scores between the
Monocryl® and Vicryl Rapide™ group at 10 days
(p = 0.14). Similarly, there were no differences in ad-
justed pain scores at any other moment in time.
Women reporting dehiscence did not have statistically
significant higher VAS scores at day 10 when compared
with women who reported no dehiscence (VAS 3.1 (SD
2.4) vs. VAS 2,5 (SD 2.3), p = 0.33). After six weeks
women reporting dehiscence (VAS 1.5 (SD 2,4)) reported
statistically significant higher pain scores than women
reporting no dehiscence (VAS 0,4 (SD 1,0)) p = 0.02.
Women who had suture material removed did not re-
port more pain when compared with women who had
no suture material removed (10 days VAS 3.2 (SD 2,8)
vs. VAS 2,6 (SD 2,3), p = 0.42 and six weeks VAS 0.7
(SD 1,8) vs. VAS 0.5 (SD 1.1), p = 0.41).
Analgesia use and VAS score did not correlate
strongly. Women who used analgesia at 24 h had VAS
scores between 2 and 10 whereas women who did not
use analgesia had VAS scores between 0 and 10. The
correlation coefficient was 0.10, with a p = 0.22 this was
not significant. After 10 days women using analgesia had
VAS scores between 1 and 8 and women who did not
use analgesia had VAS scores between 0 and 9. At day
10 the correlation coefficient was 0.22 and although at a
p = 0.01 this was significant, the correlation was weak.
After 6 weeks and 3 months all women but one had
stopped using analgesia (Additional file 2).
Discussion
Our trial showed no difference in pain scores comparing
Monocryl® and Vicryl Rapide™ for intracutaneous closure
of the skin at the time of primary repair of uncompli-
cated mediolateral episiotomies in primiparous women.
However, our trial did show significantly more self-
reported dehiscence in the Vicryl Rapide™ group as com-
pared to the Monocryl® group.
Until now only two trials compared a monofilament
and a multifilament resorbable synthetic material for the
repair of episiotomies. Dencker et al. [15] compared
suturing of all wound layers of both perineal tears and
episiotomies with a monofilament, glycomer 631, with
polyglycolic acid, a multifilament suture material. Three
days after repair no difference in wound healing was
found but after eight weeks healing complications or
necessity to remove suture material was reported signifi-
cantly more often in the monofilament group (OR 1.62,
95% CI 1.04-2.54, p = 0.034). VAS scores higher than
two at 8-12 week follow up were reported more often in
the monofilament group (RR 1.51, 95% CI 1.01-2.24,
p = 0.046). These results may be biased however, as both
intracutaneous and interrupted techniques for skin
closure were used. Due to external knots on the perineal
skin, interrupted sutures may cause the painful so-called
“barbed wire effect” [23]. It could be hypothesised that
external knots of the monofilament suture material
cause more complaints than the multifilament suture
material. As the techniques were not compared, the in-
fluence of the technique on the outcome is unclear.
Kokanali et al. [16] compared polyglycolide-co-
caprolactone, a monofilament material, with polyglactine
910 rapide with regard to healing and pain scores in
women with a mediolateral episiotomy. With a continu-
ous intracutaneous closing technique no differences in
pain scores were found between both groups at 24 h
(VAS 5.4 vs. VAS 5.7) and 10 days (VAS 2.7 vs. VAS 3.0)
after delivery.
We found significantly more frequent self-reported
dehiscence in the Vicryl Rapide™ group. These results
may put into question whether rapidly absorbable multi-
filament synthetic material is the optimal material for
perineal repair, as suggested in current guidelines [24].
In contrast to this, Dencker et al. [15] reported no
difference in dehiscence between monofilament and
multifilament suturing material at 8-12 weeks. The per-
centage of dehiscence found in the Vicryl Rapide™ 3-0
group was higher than that found in a similar group
after the use of Vicryl Rapide™ 2-0 [25]. This could pos-
sibly be caused by the caliber of the thread but could
also be attributed to the low response rate, which could
overestimate the complications in our trial due to biased
response.
A recent report suggested that resuturing of episioto-
mies in which dehiscence took place is beneficial for the
short-term complaints of women. [26] The clinical sig-
nificance of the self-reported dehiscence in our trial is
unclear. Women with dehiscence did report a higher
pain score after six weeks compared with those who did
not. Whether women with pain had a lower threshold
from where to report dehiscence is unclear. To conclude
on this issue physical examination should be included in
the trial.
In our trial 42-43% and 78-82% of women had resumed
intercourse after six week and three months respectively,
of which 41-48% and 68-80% without pain. There was no
statistically significant difference between suture materials.
These results were similar to those in some of the previ-
ous trials [7, 11] in which 33-66% of women had resumed
intercourse at 6-7 weeks and 88-98% 3 months after episi-
otomy or 2nd degree perineal rupture. Necesalova et al.
[6] found after 3 months 51% had no or rarely complaints
of dyspareunia, after 6 months this was 68%. Dyspareunia
rates found in this trial are hard to compare to ours be-
cause of a different way of questioning.
Loss to follow up was greater than expected in our
trial. Loss to follow up at 6-12 weeks in comparable
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trials varies considerably between trials, from 3.3% to
64% [9, 27].
In our trial all questionnaires were integrated in a
booklet and were given directly after delivery
Additionally, participants received text-messages as
reminders to fill out the questionnaires on day 10,
six weeks and three months after delivery. Despite
phone calls 46% of the questionnaire-booklets were
never returned. Kettle [9] and Mahomed [28] sent
questionnaires at three and/or 12 months instead of
handing the questionnaire out after delivery, leading
to 96% and 87% follow-up rate respectively. This ap-
proach may be more favourable to prevent loss to
follow up.
In our trial non-responders were on average younger
and the group contained less Caucasian women. Other
characteristics were similar between the responder and
non-responder group. Correcting for age and Caucasian
background the outcome for VAS score at 10 days and
dehiscence remained the same. Therefore we do not be-
lieve that the high number of women lost to follow up
resulted in a bias in favour of one of the two used
materials.
Strength
The main strength of our study is that we aimed to
find the best material for skin closure for a frequently
used but under-researched operative procedure, the
episiotomy. Episiotomy and its repair often cause
complaints of pain and dyspareunia in women in the
post partum period. Our trial is the third randomized
controlled trial comparing a monofilament and a fast-
absorbing multifilament suture material for episiot-
omy repair after Dencker et al. [15] and Kokanali et
al. [16]. None compared the materials used in our
study. We tried to minimize variance by including
only primiparous women with uncomplicated episi-
otomies and using a standardized technique of repair.
Limitations
One limitation was the low response rate in our trial.
Fifty-four percent of the questionnaires were returned.
As previously described we do not believe this resulted
in biased results.
Variance of Visual Analogous Scores within both
groups was large, despite efforts to maintain homogen-
eity. It is a well-known phenomenon that there is differ-
ence in pain perception among individuals and
correlation between pain scores and analgesia use in our
study was weak.. Due to the large variance, use of VAS
scores might not be optimal in similar trials, since this
requires large numbers of participants.
Dehiscence was self-reported and we did not per-
form clinical examination during the follow up period.
The clinical significance of the dehiscence is not
clear. In our trial we did not ask about complaints
apart from pain. VAS scores after 6 weeks in women
who reported dehiscence were higher than in women
who did not.
Conclusions
In our trial, pain after episiotomy repair did not differ
between skin suturing with Monocryl® or Vicryl
Rapide™. Pain scores after mediolateral episiotomy re-
pair were generally low after 6 weeks and 3 months
postpartum. Our trial is the first to report a signifi-
cant difference in dehiscence in favour of Monocryl®
compared to Vicryl Rapide™ over the three-month
study period. As pain is comparable between the two
materials, Monocryl® may therefore be slightly
superior over Vicryl Rapide™ when suturing the skin
intracutaneously in mediolateral episiotomies. It has
to be stated however that the clinical significance in
the difference of the self-reported dehiscence remains
to be determined. Further trials, preferably with clin-
ical examinations at set time points in the postpartum
period, are necessary to support these results.
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